bromodeoxyuridine has been researched along with oblimersen in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benimetskaya, L; Lai, JC; Miller, PS; Santella, RM; Stein, CA; Wang, Q | 1 |
1 other study(ies) available for bromodeoxyuridine and oblimersen
Article | Year |
---|---|
G3139 (oblimersen) may inhibit prostate cancer cell growth in a partially bis-CpG-dependent non-antisense manner.
Topics: Agar; Amino Acid Motifs; Annexin A5; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Membrane; Coloring Agents; CpG Islands; DNA; DNA Methylation; Down-Regulation; Enzyme Inhibitors; Flow Cytometry; G1 Phase; Guanosine; Humans; Male; Membrane Potentials; Mitochondria; Mutation; Oligonucleotides; Oligonucleotides, Antisense; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Reactive Oxygen Species; S Phase; Thionucleotides; Time Factors; Transfection | 2003 |